Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.51 USD | -2.25% | -50.44% | -56.53% |
04/06 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
31/05 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
1st Jan change | Capi. | |
---|---|---|
-56.53% | 1.79B | |
+18.84% | 125B | |
+15.39% | 109B | |
-1.35% | 24.74B | |
+3.00% | 22.67B | |
-9.91% | 18.14B | |
-41.04% | 16.67B | |
-11.81% | 16.64B | |
+0.94% | 13.45B | |
+23.23% | 11.32B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Inhibrx Chief Medical Officer Resigns -- Stocks Drop Amid Elevated Trading Volume